Skip to main content
Premium Trial:

Request an Annual Quote

BBSRC Awards $16M for Major Life Sciences Equipment Purchases

NEW YORK (GenomeWeb News) – The UK's Biotechnology and Biological Sciences Research Council has awarded £10 million ($16.4 million) to universities around the country to fund the purchase of big-ticket life sciences research equipment, including genomics, proteomics, and advanced microscopy technologies.

BBSRC said today that the 20 new awards, funded under the Advanced Life Sciences Research Technology (ALERT13) initiative, represent the first major equipment purchasing program the council has funded since 2007.

The technologies the grants will purchase will be used as shared resources for scientific collaborations and to benefit industry and public-sector based research projects, BBSRC said.

Among the ALERT13 grants, the University of Liverpool was awarded nearly £354,000 to establish single-molecule real-time sequencing to support projects in the north of the UK, as well as £213,000 to purchase mass spectrometry imaging technologies.

The University of Bristol received a £326,000 award to buy an Affymetrix GeneTitan to support high-throughput genotyping.

The University of Sheffield was awarded £224,000 to buy a quantitative biomolecular interaction suite, the University of Leeds received £409,000 for a high-throughput, low-volume crystallization facility, and the University of Manchester received £499,000 to fund hydrogen/deuterium Exchange and ion mobility mass spectrometry tools for use in protein interaction studies.

The full list of awards can be found here.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.